Closed-loop control of tumor growth by means of anti-angiogenic administration
From MaRDI portal
Publication:1714906
DOI10.3934/MBE.2018037zbMath1406.92286OpenAlexW2791864613WikidataQ58130359 ScholiaQ58130359MaRDI QIDQ1714906
Valerio Cusimano, Pasquale Palumbo, Federico Papa, Alfredo Germani, Filippo Cacace
Publication date: 1 February 2019
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2018037
Feedback control (93B52) Nonlinear systems in control theory (93C10) Discrete-time control/observation systems (93C55) Medical applications (general) (92C50) Observability (93B07)
Related Items (2)
Tumour growth control: analysis of alternative approaches ⋮ Effect of linearization in a WNT signaling model
Cites Work
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Local controllability and optimal control for a model of combined anticancer therapy with control delays
- Asymptotic analysis of digital control systems
- On optimal delivery of combination therapy for tumors
- Nonlinear control systems.
- Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- Design of state observers from a drift-observability property
- Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design
- A Chain Observer for Nonlinear Systems with Multiple Time-Varying Measurement Delays
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment
- A Luenberger-like observer for nonlinear systems
- State Estimation and Control of Nonlinear Systems with Large and Variable Measurement Delays
This page was built for publication: Closed-loop control of tumor growth by means of anti-angiogenic administration
